Tfc Financial Management Akero Therapeutics, Inc. Transaction History
Tfc Financial Management
- $650 Million
- Q1 2025
A detailed history of Tfc Financial Management transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Tfc Financial Management holds 2 shares of AKRO stock, worth $81. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2Holding current value
$81% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
210Shares Held
67.5MCall Options Held
321KPut Options Held
558K-
Rtw Investments, LP New York, NY6.86MShares$281 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$247 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$229 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$215 Million5.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.32MShares$177 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.9B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...